Table 3.
Comparative summary of the studies reporting on SBRT treatment of adrenal gland metastases
| Author | No. of patients | Histology | Dose (Gy)/Fractionation | Median/Mean follow-up (mo) | Local control (%) | Overall survival (%) |
|---|---|---|---|---|---|---|
| Katoh et al. (2008) [22] | 8 | Miscellaneous | 30-48/8 | 16 | 1 Yr: 100 | 1 Yr: 78 |
| 2 Yr: 100 | - | |||||
| Chawla et al. (2009) [21] | 30 | Miscellaneous | 16-50/4-10 | 9.8 | 1 Yr: 55 | 1 Yr: 44 |
| 2 Yr: 27 | 2 Yr: 25 | |||||
| Torok et al. (2011) [23] | 7 | Miscellaneous | 10-36/3 | 14 | 1 Yr: 63 | - |
| Oshiro et al. (2011) [3] | 11 | Lung | 30-60/1-27 | 10.1 | 6 Mo: 97.4 | 1 Yr: 55.6 |
| - | 2 Yr: 33.4 | |||||
| Holy et al. (2011) [24] | 18 | Lung | 20-40/5 | 12 | 1 Yr: 94.4 | - |
| 2 Yr: 78.7 | - | |||||
| Casamassima et al. (2012) [20] | 48 | Miscellaneous | 21-54/3 | 16.2 | 1 Yr: 90 | 1 Yr: 39.7 |
| 2 Yr: 90 | 2 Yr: 14.5 | |||||
| Ahmed et al. (2013) [25] | 9 | Lung | 20-37.5/5 | 7.3 | 1 Yr: 44 | 1 Yr: 62.9 |
| 2 Yr: 44 | - | |||||
| Romero Arenas et al. (2014) [26] | 13 | Miscellaneous | 33.7-60/5 | 12.3 | Crude: 100 | 1 Yr: 62.9 |
| This study | 47 | Miscellaneous | 40/4 | 11.3 | 1 Yr: 65.5 | 1 Yr: 87.6 |
| 2 Yr: 40.1 | 2 Yr: 87.6 |
SBRT, stereotactic body radiation therapy.